Malignant ascites as only manifestation of metastatic prostate cancer

Autor: William L. Dahut, William D. Figg, Stephen M. Hewitt, Eddie Reed, MW Saif, K Brosky

Publikováno v: Prostate Cancer and Prostatic Diseases. 2:290-293

Prostate cancer is the most common malignancy in men in the US. Both at diagnosis and throughout the disease progression it can metastasize to multiple organs (bone and lymph being the most common). Effusions (either pleural or abdominal) are relativ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c661a2481d42d295f591a13550b7935b
https://doi.org/10.1038/sj.pcan.4500385

RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth.

Autor: Bannoura SF; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Aboukameel A; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Khan HY; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Uddin MH; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Jang H; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Beal EW; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Thangasamy A; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Shi Y; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Kim S; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Wagner KU; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Beydoun R; Department of Pathology, Wayne State University School of Medicine/Detroit Medical Center, Detroit, MI, USA., El-Rayes BF; O'Neal Comprehensive Cancer Center, Division of Hematology Oncology, University of Alabama, Birmingham, AL, USA., Philip PA; Henry Ford Cancer Institute, Henry Ford Health, Detroit, MI, USA., Mohammad RM; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Saif MW; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Al-Hallak MN; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Pasche BC; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Azmi AS; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA. Electronic address: azmia@karmanos.org.

Publikováno v: Cancer letters [Cancer Lett] 2024 Nov 01; Vol. 604, pp. 217275. Date of Electronic Publication: 2024 Sep 24.

Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.

Autor: Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Graduate School, Seoul, South Korea. ohdoyoun@snu.ac.kr., Maqueda MA; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Quinn DI; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA., Chau I; The Royal Marsden NHS Foundation Trust-Royal Marsden Hospital, London, UK., Kim SY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Duran I; Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain., Castellano D; Hospital Universitario, 12 de Octubre, Madrid, Spain., Berlin J; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Mellado B; Medical Oncology Department, Hospital Clinic i Provincial de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Williamson SK; University of Kansas Hospital Cancer Center, Kansas City, KS, USA., Lee KW; Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea., Marti F; The Christie NHS Foundation Trust, Manchester, UK., Mathew P; Tufts Medical Center, Boston, MA, USA., Saif MW; Tufts Medical Center, Boston, MA, USA.; Orlando Health Cancer Institute, Orlando, FL, USA., Wang D; Henry Ford Hospital, Detroit, MI, USA., Chong E; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USA., Hilger-Rolfe J; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USA., Dean JP; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USA., Arkenau HT; Sarah Cannon Research Institute - United Kingdom (SCRI-UK) and University College London, Cancer Institute, London, UK.

Publikováno v: BMC cancer [BMC Cancer] 2023 Nov 03; Vol. 23 (1), pp. 1056. Date of Electronic Publication: 2023 Nov 03.

Analysis of Updates in Multiple Myeloma Treatment and Management.

Autor: Nieto MJ; Department of Cancer, Northwell Health Cancer Institute & Donald and Barbara Zucker School of Medicine at Hofstra, Lake Success, NY, USA., Hedjar A; Department of Cancer, Northwell Health Cancer Institute & Donald and Barbara Zucker School of Medicine at Hofstra, Lake Success, NY, USA., Locke M; Department of Cancer, Northwell Health Cancer Institute & Donald and Barbara Zucker School of Medicine at Hofstra, Lake Success, NY, USA., Caro J; Department of Cancer, Northwell Health Cancer Institute & Donald and Barbara Zucker School of Medicine at Hofstra, Lake Success, NY, USA., Saif MW; Orlando Health Cancer Institute, Orlando, FL, USA.

Publikováno v: Journal of clinical haematology [J Clin Haematol] 2023; Vol. 4 (1), pp. 35-42.

Rectal Dieulafoy's lesion: a comprehensive review of patient characteristics, presentation patterns, diagnosis, management, and clinical outcomes.

Autor: Inayat F; Allama Iqbal Medical College, Lahore, Pakistan., Hussain A; Allama Iqbal Medical College, Lahore, Pakistan., Yahya S; Fatima Jinnah Medical University, Lahore, Pakistan., Weissman S; Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ, USA., Sarfraz N; King Edward Medical University, Lahore, Pakistan., Faisal MS; Allegheny General Hospital, Pittsburgh, PA, USA., Riaz I; Einstein Medical Center, Philadelphia, PA, USA., Saleem S; Mercy Saint Vincent Medical Center, Toledo, OH, USA., Saif MW; The Feinstein Institute of Medical Research, Manhasset, NY, USA.; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

Publikováno v: Translational gastroenterology and hepatology [Transl Gastroenterol Hepatol] 2022 Jan 25; Vol. 7, pp. 10. Date of Electronic Publication: 2022 Jan 25 (Print Publication: 2022).